Edited: Huang Sheng
This week, following the after-hours announcement of Sugon and Daye shares on Thursday after the illegal short-term trading of directors or relatives of senior executives, Kangyuan Pharmaceutical and Senba Sensing announced after hours on Friday that the spouses of independent directors or executives bought and sold the company's shares, constituting short-term trading.
In addition, according to incomplete statistics, since April, Huali Shares, Hongbo Pharmaceutical and Hongyuan Pharmaceutical have announced illegal short-term transactions by relatives of directors, supervisors and senior executives. From January to March this year, 28 A-share listed companies have disclosed that directors, supervisors, senior executives, or their relatives, as well as shareholders holding more than 5% of the shares, are suspected of short-term trading.
Accordingly, a total of 35 A-share listed companies have experienced this situation since the beginning of this year.
Image source: Photo by Wen Duo, Daily Economic News
Four A-share listed companies announced this week that the relatives of directors, supervisors and senior executives violated short-term trading
After trading on Friday, Kangyuan Pharmaceutical Co., Ltd. (600557. SH, share price of 21.24 yuan, market value of 12.42 billion yuan) announced that Mr. Duan Jinxiao, an independent director of the company, issued the "Explanation on the Trading of Company Shares by My Spouse" because his spouse Ms. Cai Zhenli bought and sold the company's shares from October 20, 2023 to December 20, 2023. According to the relevant regulations, the above transactions constitute short-term transactions. After verification, Cai Zhenli bought a total of 8,600 shares of the company's shares (3 transactions) during the above period, with a total turnover of 137,700 yuan, and sold 8,600 shares of the company's shares (1 transaction), with a total turnover of 186,300 yuan. After deducting various transaction costs of 172.63 yuan, the income generated by this short-term transaction was 48,400 yuan. As of the disclosure date of the announcement, Cai Zhenli no longer holds the company's shares. As of the date of this announcement, all the proceeds from the above-mentioned short-term trading have been handed over to the company.
Kangyuan Pharmaceutical announced on the same day that its net profit in the first quarter of 2024 was 148 million yuan, a year-on-year increase of 4.67%. In the secondary market, Kangyuan Pharmaceutical's stock price rose by 43.13% from October 20 to December 20, 2023, and then took a sharp turn, with a cumulative maximum decline of 39.55% from December 20, 2023 to February 5, 2024.
After trading on Friday, Senba Sensing (300701. SZ, share price of 7.96 yuan, market value of 2.251 billion yuan) announced that the company recently received the "Explanation of Short-term Trading and Apology for My Relatives" issued by Deng Zaihong, a senior manager of the company. It was learned that Deng Zaihong's spouse, Fu Daosheng, had recently bought and sold shares of the company, which constituted short-term trading. According to the announcement, Fu Daosheng bought 20,000 shares, 10,000 shares, and 10,000 shares of Senba Sensing shares on January 31, February 6, and February 19 respectively, and sold 40,000 shares of Senba Sensing shares on February 27, generating a short-term transaction of 46,584.23 yuan. From the perspective of secondary market performance, the cumulative maximum decline in the stock price of Senba Sensing from the high point in January to the low point on February 7 was 55.23%, and then stabilized and fluctuated upward, with the largest cumulative increase of 78.95% so far from the low point in February.
On Thursday evening, Sugon (603019. SH, share price 45 yuan, market value 65.861 billion yuan) announced that the company recently received the company's chairman Li Guojie with the "Explanation of the Situation and Apology Letter on Short-term Transactions of Relatives". For the basic situation of this short-term transaction, the announcement mentioned that after verification, Zhang Dihua, the spouse of Li Guojie, chairman of the company, has held the company's shares since March 3, 2023, and bought a total of 3,343,300 shares (141 transactions) of the company's shares from March 3, 2023 to March 14, 2024, with a total turnover of 154 million yuan, and sold a total of 3,342,600 shares (91 transactions) of the company's shares, with a total turnover of 154 million yuan (rounded); The cumulative income after stamp duty and other taxes is 589,800 yuan (which has been fully handed over to the company). On Thursday evening, the Shanghai Stock Exchange quickly issued a regulatory work letter to Sugon, clarifying the regulatory requirements for short-term trading of relatives of the company's directors.
Sugon released a performance report in February, with a net profit of 1.838 billion yuan in 2023, a year-on-year increase of 19%. In the long run, Sugon's stock price has risen by 98% from March 3 to mid-June 2023, and the stock price has risen by 112.64% so far. It is worth noting that looking back at the announcement of illegal short-term trading by the relatives of directors, supervisors and senior executives of all A-share listed companies during the year, from the perspective of short-term transaction amount, the investment amount of the spouse of the chairman of Sugon ranks in the forefront.
On Thursday evening, Daye Co., Ltd. (300879. SZ, share price 13.87 yuan, market value 2.219 billion yuan) announced that Ms. Wu Hongmei, the spouse of Mr. Yin Kaijun, a senior manager of the company, bought the company's shares on February 7, 2024 and sold the company's shares on February 8, 2024, constituting a short-term transaction. The announcement disclosed that calculated according to the first-in-first-out principle, the income of this short-term transaction was 123 yuan.
Daye Co., Ltd. disclosed the performance forecast on January 30, and it is expected that the net profit loss attributable to the parent company in 2023 will be 110 million yuan to 148 million yuan, compared with 11.2511 million yuan in the same period last year. In the long run, Daye's stock price has risen by 104.16% since the low point on February 7.
Daily Economic News comprehensive public information
Disclaimer: The content and data in this article are for reference only and do not constitute investment advice. Do so at your own risk.
National Business Daily